24 Venous thromboembolism
Health care setting
Acute care or primary care, often following prolonged or complicated hospitalization
Assessment
Signs and symptoms:
Assessments may be divided into those in the area of the thrombus (associated with inflammation) and those distal to the clot (associated with venous congestion). Over the site of the thrombus, signs and symptoms can include pain, tenderness, erythema, local warmth, and increased limb circumference. Distal to the area of thrombus, the extremity may be cool, pale or cyanotic, and edematous and will display prominent superficial veins. Additional findings include unilateral leg swelling, fever, and tachycardia. Sometimes the condition is clinically “silent,” and the late presenting sign may be a PE. (See “Pulmonary Embolus,” p. 125.)
Diagnostic tests
Plasma markers (D-dimer test):
A positive plasma D-dimer test is indicative of fibrin breakdown, and further evaluation is warranted. A negative D-dimer test is helpful in excluding DVT if noninvasive testing also is negative.
Nursing diagnoses:
Risk for decreased cardiac perfusion
related to thrombus formation or embolization
ASSESSMENT/INTERVENTIONS | RATIONALES |
---|---|
Assess for lower extremity pain, erythema, increased limb girth, local warmth, distal pale skin, edema, and venous dilation. If indicators appear, maintain patient on bedrest and notify health care provider promptly. | These are early indicators of peripheral thrombus formation (DVT), which necessitate bedrest and prompt medical attention to prevent embolization. |
Assess for and immediately report sudden onset of chest pain, dyspnea, tachypnea, tachycardia, hypotension, hemoptysis, shallow respirations, crackles (rales), O2 saturation 92% or less, decreased breath sounds, and diaphoresis. | These are signs of PE, a life-threatening situation. If they occur, prompt medical attention is crucial. |
Administer anticoagulants as prescribed. | Anticoagulants prevent propagation of a clot. Heparin is used during the acute phase, and long-term warfarin therapy is used after the acute phase. Six months of anticoagulation is recommended for a first occurrence of DVT. Low-molecular-weight heparin may be prescribed, enabling outpatient management of DVT until warfarin levels are therapeutic. < div class='tao-gold-member'>
Only gold members can continue reading. Log In or Register a > to continue
Stay updated, free articles. Join our Telegram channelFull access? Get Clinical TreeGet Clinical Tree app for offline access |